Statistical Analysis Plan for the Aspiring to Reduce Events in Dialysis (ASPIRED) Trial
Billot, L.; Coggan, S.; Fan, L.; Perkovic, V.; Yu, X.; Badve, S. V.; Jardine, M.; Tan, N.; Chen, W.; Monaghan, H.; Chen, M.; He, Z.; Ma, G.; Kotwal, S.; Wong, M. G.
Show abstract
The ASPIRED trial aims to determine whether a daily low-dose of aspirin is effective in preventing major cardiovascular events when compared to placebo in patients receiving dialysis. It is designed as a pragmatic trial two-arm double-blind randomised trial conducted within an established Dialysis Registry consisting of at least 80 centres and 30,000 participants. This statistical analysis plan pre-specifies the method of analysis for every outcome and key variables collected in the trial. The primary outcome is time from randomisation to first occurrence of major cardiovascular event including myocardial infarction, ischemic stroke or death from cardiovascular cause. The primary analysis will consist in a Cox proportional hazard model adjusted for stratification variables. The analysis plan also includes planned sensitivity analyses including covariate adjustments and subgroup analyses.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol 93%
- Using numerical modelling and simulation to assess the ethical burden in clinical trials and how it relates to the proportion of responders in a trial sample 93%
- Randomised, controlled, feasibility trial comparing vasopressor infusion administered via peripheral cannula versus central venous catheter for critically ill adults: a study protocol 93%
Similar papers in this journal
- Real-world effects of ACE inhibitors and Angiotensin Receptor Blockers: protocol for an emulation study of the ONTARGET trial using electronic health records 96%
- RESEARCH PROTOCOL: Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus 94%
- CATALYST trial protocol: A multicentre, open-label, phase II, multi-arm trial for an early and accelerated evaluation of the potential treatments for COVID-19 in hospitalised adults 93%
Similar papers in this journal
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 96%
- Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome (DeVENT study) – Trial Protocol 93%
- Evaluating Diuretics in Normal Care (EVIDENCE): Protocol of a cluster randomised controlled equivalence trial of prescribing policy to compare the effectiveness of thiazide-type diuretics in hypertension. 93%
Similar papers in this journal
- Preprint server use in kidney disease research: a rapid review 92%
- The mediating role of trust in physicians on the association between multidimensional health literacy and medication adherence in hemodialysis: A cross-sectional study 90%
- Comparison of low eGFR prevalence and prediction for mortality using 2009 and 2021 CKD-EPI equations in Mexican adults 89%
Similar papers in this journal
- The Proportion of Randomized Controlled Trials That Inform Clinical Practice: A Longitudinal Cohort Study of Trials Registered on ClinicalTrials.gov 92%
- Systematic analysis of electronic health records identifies drugs reducing risk of COVID-19 hospitalization and severity 89%
- Multicenter preclinical studies as an innovative method to enhance translation: a systematic review of published studies 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.